| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.07 (Beat by $0.01) |
| EPS GAAP Actual | $0.07 (Beat by $0.01) |
| Revenue Actual | $0.011251B |
| Revenue Surprise | Beat by $11.251M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.02 |
| EPS GAAP Estimate | $-0.02 |
| Revenue Estimate | $0.070174B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.08 | 148.25 | 0.07952656 | 0.08033884 | 1 |
| Dec 2025 | -0.08 | -148.25 | -0.08 | -0.08 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0112 | 0.0412 | 0.011251B | -18.36% | -1.05M |
| FQ2 2025 (Jun 2025) | 0.17 | 0.17 | 0.00996B | -14.91% | 9.96M |
| FQ1 2025 (Mar 2025) | 0.03 | 0.03 | 0.010252B | -16.95% | 10.25M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.021474B | -0.55% | 21.47M |
| FQ3 2024 (Sep 2024) | 0.0375 | 0.0375 | 0.013317B | 12.77% | 13.32M |
| FQ4 2012 (Dec 2012) | 0 | 0 | 0.00057958B | 100% | 0.58M |
| FQ2 2024 (Jun 2024) | -0.0419 | -0.0419 | 0.011445B | -1.21% | 11.45M |
| FQ1 2024 (Mar 2024) | 0.0127 | 0.0127 | 0.01199B | -5.69% | 11.99M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.02
Consensus Revenue Estimates
0.070174B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.15 | -- | 0.15 | 0.15 | 1 |
| FQ3 2027 (Sep 2027) | 0.03 | -- | 0.03 | 0.03 | 1 |
| FQ2 2027 (Jun 2027) | -0.01 | -- | -0.0106165 | -0.0093835 | 1 |
| FQ1 2027 (Mar 2027) | 0.02 | -- | 0.01876699 | 0.02123301 | 1 |
| FQ4 2026 (Oct 2026) | -0.01 | -- | -0.01032493 | -0.00967507 | 0 |
| FQ3 2026 (Jul 2026) | -0.03 | 137.33 | -0.0309748 | -0.0290252 | 0 |
| FQ2 2026 (Jun 2026) | -0.04 | 525 | -0.04119863 | -0.0392453 | 0 |
| FQ1 2026 (Mar 2026) | -0.02 | 250 | -0.02059932 | -0.01962265 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2027 (Sep 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ2 2027 (Jun 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ1 2027 (Mar 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ4 2026 (Oct 2026) | 0.01B | -- | 0.01B | 0.01B | 0 |
| FQ3 2026 (Jul 2026) | 0.01B | 10.69 | 0.01B | 0.01B | 0 |
| FQ2 2026 (Jun 2026) | 0.08B | 86.82 | 0.07B | 0.08B | 1 |
| FQ1 2026 (Mar 2026) | 0.07B | 85.39 | 0.07B | 0.07B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.03 | 0.0112 | 0.0412 | 367.86% |
| FQ2 2025 (Jun 2025) | 0.17 | 0.17 | 100% | |
| FQ1 2025 (Mar 2025) | 0.03 | 0.03 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0.0375 | 0.0375 | 100% | |
| FQ4 2012 (Dec 2012) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | -0.0419 | -0.0419 | 100% | |
| FQ1 2024 (Mar 2024) | 0.0127 | 0.0127 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.01B | $0.01B | $-1.05M | -9.32% |
| FQ2 2025 (Jun 2025) | $0B | $0.01B | $9.96M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.01B | $10.25M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.02B | $21.47M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.01B | $13.32M | 100% |
| FQ4 2012 (Dec 2012) | $0B | $0B | $0.58M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.01B | $11.45M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.01B | $11.99M | 100% |